Prevalence, Severity and Mortality associated with COPD and Smoking in patients with COVID-19: A Rapid Systematic Review and Meta-Analysis.
<h4>Background</h4>Coronavirus disease 2019 (COVID-19) is an evolving infectious disease that dramatically spread all over the world in the early part of 2020. No studies have yet summarized the potential severity and mortality risks caused by COVID-19 in patients with chronic obstructiv...
Main Authors: | Jaber S Alqahtani, Tope Oyelade, Abdulelah M Aldhahir, Saeed M Alghamdi, Mater Almehmadi, Abdullah S Alqahtani, Shumonta Quaderi, Swapna Mandal, John R Hurst |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2020-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0233147 |
Similar Items
-
Smoking cessation during COVID-19: the top to-do list
by: Jaber S. Alqahtani, et al.
Published: (2021-05-01) -
Reduction in hospitalised COPD exacerbations during COVID-19: A systematic review and meta-analysis.
by: Jaber S Alqahtani, et al.
Published: (2021-01-01) -
Current status of telehealth in Saudi Arabia during COVID-19
by: Saeed M Alghamdi, et al.
Published: (2020-01-01) -
Once Daily Versus Overnight and Symptom Versus Physiological Monitoring to Detect Exacerbations of Chronic Obstructive Pulmonary Disease: Pilot Randomized Controlled Trial
by: Al Rajeh, Ahmed M, et al.
Published: (2020-11-01) -
A double-blind randomised controlled trial of protein supplementation to enhance exercise capacity in COPD during pulmonary rehabilitation: a pilot study
by: Abdulelah M. Aldhahir, et al.
Published: (2021-03-01)